Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
0(0%)
Results Posted
27%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
2
15%
Ph not_applicable
1
8%
Ph phase_4
1
8%
Ph phase_3
3
23%
Ph phase_1
6
46%

Phase Distribution

6

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
6(46.2%)
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(11)
Terminated(2)

Detailed Status

Completed11
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (46.2%)
Phase 22 (15.4%)
Phase 33 (23.1%)
Phase 41 (7.7%)
N/A1 (7.7%)

Trials by Status

terminated18%
withdrawn18%
completed1185%

Recent Activity

0 active trials
Showing 5 of 13
completedphase_2

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00840177
completedphase_3

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

NCT00006412
completedphase_1

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

NCT00000941
completedphase_1

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

NCT00834379
completedphase_3

Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis

NCT01075555
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT00840177Phase 2

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

Completed
NCT00006412Phase 3

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Completed
NCT00000941Phase 1

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Completed
NCT00834379Phase 1

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Completed
NCT01075555Phase 3

Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis

Completed
NCT01831232Not Applicable

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Completed
NCT01342887Phase 1

Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Terminated
NCT01515813Phase 2

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Withdrawn
NCT00433498Phase 3

Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer

Completed
NCT01146093Phase 1

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions

Completed
NCT00382460Phase 4

Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

Completed
NCT01146106Phase 1

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Completed
NCT00017758Phase 1

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13